The U.S. Food and Drug Administration has approved RayOne EMV (Rayner), a fully preloaded non-diffractive IOL, according to a press release.
The IOL was developed in collaboration with Professor Graham Barrett, president of the Australasian Society of Cataract & Refractive Surgeons.
“Following approval of our RayOne and RayPRO platforms in 2019 we have been steadily increasing our investment in the USA to be one of our most important markets worldwide,” Tim Clover, Rayner CEO, said in a company news release. “The approval of RayOne EMV is important as it allows surgeons to offer patients a new option which has been tried and tested in thousands of patients around the world”
Read the full press release here.